About Zinc finger protein 641
Zinc finger protein 641 (ZNF641) is a protein
from Homo sapiens identified by UniProt accession
Q96N77, 438 residues long.
MolForge cross-references it against 0 known binders and
67 disease associations.
Target properties
| Protein name | Zinc finger protein 641 |
| UniProt accession | Q96N77 |
| Gene | ZNF641 |
| Organism | Homo sapiens |
| Length | 438 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (67)
Diseases linked to this target (Open Targets).
- glomerular filtration rate · score 0.36
- hematocrit · score 0.29
- creatinine measurement · score 0.29
- neurodegenerative disease · score 0.28
- hemoglobin measurement · score 0.26
- sitting height measurement · score 0.25
- erythrocyte count · score 0.24
- bilirubin measurement · score 0.23
- systolic blood pressure · score 0.20
- type 2 diabetes mellitus · score 0.18
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96N77-F1 | alphafold | PREDICTED | 48.82 | — |
Amino-acid sequence (438 residues)
MQAEDRSQFG SAAEMLSEQT AALGTGWESM NVQLDGAEPQ VERGSQEERP WRTVPGPLEH LCCDLEEEPQ SLQEKAQSAP WVPAIPQEGN TGDWEMAAAL LAAGSQGLVT IKDVSLCFSQ EEWRSLDPSQ TDFYGEYVMQ ENCGIVVSLR FPIPKLDMLS QLEGGEEQWV PDPQDLEERD ILRVTYTGDG SEHEGDTPEL EAEPPRMLSS VSEDTVLWNP EHDESWDSMP SSSRGMLLGP PFLQEDSFSN LLCSTEMDSL LRPHTCPQCG KQFVWGSHLA RHQQTHTGER PYSCLKCEKT FGRRHHLIRH QKTHLHDKTS RCSECGKNFR CNSHLASHQR VHAEGKSCKG QEVGESPGTR KRQRAPPVPK CHVCTECGKS FGRRHHLVRH WLTHTGEKPF QCPRCEKSFG RKHHLDRHLL THQGQSPRNS WDRGTSVF
Explore Zinc finger protein 641 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets